Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas
暂无分享,去创建一个
K. D. Sørensen | Philippe Lamy | Bodil Øster | T. Ørntoft | C. Andersen | K. Birkenkamp-Demtröder | S. Laurberg | L. Hansen | K. Thorsen | P. Lamy | Kasper Thorsen | Søren Laurberg | Claus L. Andersen | T. Wojdacz | Torben F. Ørntoft | Tomasz K. Wojdacz | Lise Lotte Hansen | Karin Birkenkamp‐Demtröder | Karina D. Sørensen | B. Øster
[1] S. J. Mills,et al. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[2] L. de Leval,et al. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples. , 2010, European urology.
[3] I. Bièche,et al. Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers , 2004, British Journal of Cancer.
[4] W. Gerald,et al. A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies , 2006, PLoS medicine.
[5] M. Fackler,et al. DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma , 2003, International journal of cancer.
[6] P. Laird,et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.
[7] N. Matsubara,et al. Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer. , 2007, Gastroenterology.
[8] J. Herman,et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. , 2009, Cancer research.
[9] Yoko Ito,et al. The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene , 2009, Oncogene.
[10] S. Baylin,et al. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[11] Zsolt Tulassay,et al. Identification and Validation of Colorectal Neoplasia–Specific Methylation Markers for Accurate Classification of Disease , 2007, Molecular Cancer Research.
[12] A. Goel,et al. Role of hMLH1 promoter hypermethylation in drug resistance to 5‐fluorouracil in colorectal cancer cell lines , 2003, International journal of cancer.
[13] P. V. van Diest,et al. Methylation of the TWIST1 Promoter, TWIST1 mRNA Levels, and Immunohistochemical Expression of TWIST1 in Breast Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[14] D. Ward,et al. Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.
[15] H. Aburatani,et al. Three DNA Methylation Epigenotypes in Human Colorectal Cancer , 2009, Clinical Cancer Research.
[16] R. Beart,et al. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.
[17] D. Ahlquist,et al. Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[18] W. Pavan,et al. NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation , 2009, Pigment cell & melanoma research.
[19] Tim Hui-Ming Huang,et al. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] Klaus Jung,et al. Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis. , 2007, The Journal of urology.
[21] Claus Lindbjerg Andersen,et al. Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets , 2004, Cancer Research.
[22] M. Washington,et al. Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA. , 2009, Clinical chemistry.
[23] Kurt Berlin,et al. Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection , 2006, Nucleic acids research.
[24] Yvonne Wallis,et al. The Wnt Antagonist sFRP1 in Colorectal Tumorigenesis , 2004, Cancer Research.
[25] J. Herman,et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.
[26] J. Herman,et al. Association between CpG island methylation and microsatellite instability in colorectal cancer. , 1997, Cancer research.
[27] J. Herman,et al. CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] N. Kiviat,et al. Detection of hypermethylated genes in women with and without cervical neoplasia. , 2005, Journal of the National Cancer Institute.
[29] Jose M. Silva,et al. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] A. Feinberg,et al. Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.
[31] F. López-Ríos,et al. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer , 2010, Oncogene.
[32] Mark D. Robinson,et al. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity , 2010, Nature Cell Biology.
[33] A. Duval,et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2002, Gastroenterology.
[34] Clare Stirzaker,et al. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band , 2006, Nature Genetics.
[35] Owen T McCann,et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. , 2010, Genome research.
[36] S. Ackerman,et al. Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. , 2007, Gastroenterology.
[37] S. Baylin,et al. HIC1 hypermethylation is a late event in hematopoietic neoplasms. , 1997, Cancer research.
[38] J. Herman,et al. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. , 2008, Cancer research.
[39] T. Ørntoft,et al. Secretagogin Is a Novel Marker for Neuroendocrine Differentiation , 2006, Neuroendocrinology.
[40] Mihaela Campan,et al. DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis , 2008, Laboratory Investigation.
[41] A. Dobrovic,et al. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation , 2007, Nucleic acids research.
[42] D. Ahlquist,et al. Frequent Methylation of Eyes Absent 4 Gene in Barrett's Esophagus and Esophageal Adenocarcinoma , 2005, Cancer Epidemiology Biomarkers & Prevention.
[43] Wendy Cozen,et al. Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma , 2007, Molecular Cancer.
[44] M. Oka,et al. TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancer , 2010, Genes, chromosomes & cancer.